semaglutide discontinuation Yet another study showing high rate of both and tirzepatide up to 50% at 1 year in the real world Small NAION Risk from GLP-1

(Link) Molina Healthcares Bright HealthCare Deal: Molina Healthcare revised terms for acquiring Bright HealthCares Medicare business in California: (Link) The purchase price for the transaction, net of certain tax benefits, is reduced from the previously announced $510 million to approximately $425 million, and now represents 23% of expected 2023 premium revenue of $1.8 billion

Features and development of Coot

10.2131/jts.48.487 116 SunZ.ShiK.YangS.LiuJ.ZhouQ.WangG.et al (2018)

At Noom, he will help translate behavioral science into practical frameworks for GLP-1 members, shaping content, coaching, and product strategy

The second counter is the consistency problem

Tirzepatide is a medical therapy, not a quick fix, and it requires ongoing medical supervision. Side effects, most often nausea, vomiting, diarrhea, or constipation, are common, especially as the dose increases